Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00707824Phase 4Completed
Phase 4, randomised, double-blind trial of nalbuphine in pruritus (3 arms), sponsored by Mahidol University. Primary endpoints: Incidence of postoperative pruritus at 24 hours and Severity of postoperative pruritus at 24 hours. Started Jun 2000; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00707824.